Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Diseases, Interstitial × Prednisone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 219 Lymphoma, Large B-Cell, Diffuse 160 Lymphoma 158 Precursor Cell Lymphoblastic Leukemia-Lymphoma 78 Lymphoma, Follicular 74 Lymphoma, Non-Hodgkin 67 Burkitt Lymphoma 63 Multiple Myeloma 58 Leukemia 51 Hodgkin Disease 41 Lymphoma, Mantle-Cell 37 Neoplasms 31 Lymphoma, T-Cell, Peripheral 29 Lymphoma, B-Cell 27 Lymphoma, B-Cell, Marginal Zone 26 Neoplasm Metastasis 24 Lymphoma, Large-Cell, Immunoblastic 24 Lymphoma, Large-Cell, Anaplastic 24 Leukemia, Lymphocytic, Chronic, B-Cell 21 Neoplasms, Plasma Cell 20 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 19 Recurrence 16 Dendritic Cell Sarcoma, Interdigitating 14 Immunoblastic Lymphadenopathy 13 Lymphoma, T-Cell 9 Waldenstrom Macroglobulinemia 8 Primary Myelofibrosis 8 Myelodysplastic Syndromes 8 Myasthenia Gravis 8 Leukemia, Biphenotypic, Acute 8

Interventions

pembrolizumab 2 perflutren 1 Vinorelbine 1 Thoracoscopy 1 Sulfur Hexafluoride 1 Radiotherapy 1 Prednisone 1 Pemetrexed 1 Paclitaxel 1 Nivolumab 1 Lidocaine 1 Lenalidomide 1 Immune Checkpoint Inhibitors 1 Hypnosis 1 Gemcitabine 1 Drug Therapy 1 Drug Delivery Systems 1 Dexamethasone 1 Conscious Sedation 1 Clinical Protocols 1 Carboplatin 1 Bronchoscopy 1 Bronchoalveolar Lavage 1 Blood Pressure 1 Bevacizumab 1 Behavior Therapy 1 Adrenal Cortex Hormones 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04036721 2023-02-23

PROS-CONS

National Institute for Tuberculosis and Lung Diseases, Poland

Phase 4 Suspended

Lung Neoplasms, Pneumonia, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡